Inficon (IFCN SW) – FY sales +11% at 211.7m / EBIT 26.8m / net profit +42% at 22m > good figures Outlook: plans share buyback program of up to CHF 40m – plans to raise dividend to CHF 6 (vs CHF 5) – sees 2007 sales growth of 10% and EBIT margin 13-14% (before sales growth 10-15%, EBIT margin unchanged) (BB)

SwissRe (RUKN VX) – non-life renewals rise 14% to CHF 1.3bn – premium volume at CHF 10.3bn – says market conditions remain very favorable (BB)

Cytos (CYTN SW) – to sell up to CHF 70m in convertible bond – 5 years – 2.5-3% return (BB)

SGS (SGSN VX) – company buys Canadian company Synnoflex – no terms disclosed (BB)

Temenos (TEMN SW) – was rated “Leader” by Forrester Research (BB)